Global Genetic Disorders Drug Market Professional Survey Report 2019


The global Genetic Disorders Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Genetic Disorders Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Genetic Disorders Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Genetic Disorders Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Genetic Disorders Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi
Vertex
Shire
Amgen
GW Pharmaceuticals
Pfizer
BioMarin
Sarepta

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cystic Fibrosis (CF)
Duchenne Muscular Dystrophy (DMD)
Lysosomal Storage Disease (LSD)
Paroxysmal Nocturnal Hemoglobinuria (PNH)

Segment by Application
Clinic
Hospital

Table of Contents

Executive Summary
1 Industry Overview of Genetic Disorders Drug
1.1 Definition of Genetic Disorders Drug
1.2 Genetic Disorders Drug Segment by Type
1.2.1 Global Genetic Disorders Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cystic Fibrosis (CF)
1.2.3 Duchenne Muscular Dystrophy (DMD)
1.2.4 Lysosomal Storage Disease (LSD)
1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
1.3 Genetic Disorders Drug Segment by Applications
1.3.1 Global Genetic Disorders Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Genetic Disorders Drug Overall Market
1.4.1 Global Genetic Disorders Drug Revenue (2014-2025)
1.4.2 Global Genetic Disorders Drug Production (2014-2025)
1.4.3 North America Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.4 Europe Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.5 China Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.6 Japan Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Genetic Disorders Drug Status and Prospect (2014-2025)
1.4.8 India Genetic Disorders Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Genetic Disorders Drug
2.3 Manufacturing Process Analysis of Genetic Disorders Drug
2.4 Industry Chain Structure of Genetic Disorders Drug

3 Development and Manufacturing Plants Analysis of Genetic Disorders Drug
3.1 Capacity and Commercial Production Date
3.2 Global Genetic Disorders Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Genetic Disorders Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Genetic Disorders Drug Production and Capacity Analysis
4.2 Genetic Disorders Drug Revenue Analysis
4.3 Genetic Disorders Drug Price Analysis
4.4 Market Concentration Degree

5 Genetic Disorders Drug Regional Market Analysis
5.1 Genetic Disorders Drug Production by Regions
5.1.1 Global Genetic Disorders Drug Production by Regions
5.1.2 Global Genetic Disorders Drug Revenue by Regions
5.2 Genetic Disorders Drug Consumption by Regions
5.3 North America Genetic Disorders Drug Market Analysis
5.3.1 North America Genetic Disorders Drug Production
5.3.2 North America Genetic Disorders Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Genetic Disorders Drug Import and Export
5.4 Europe Genetic Disorders Drug Market Analysis
5.4.1 Europe Genetic Disorders Drug Production
5.4.2 Europe Genetic Disorders Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Genetic Disorders Drug Import and Export
5.5 China Genetic Disorders Drug Market Analysis
5.5.1 China Genetic Disorders Drug Production
5.5.2 China Genetic Disorders Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Genetic Disorders Drug Import and Export
5.6 Japan Genetic Disorders Drug Market Analysis
5.6.1 Japan Genetic Disorders Drug Production
5.6.2 Japan Genetic Disorders Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Genetic Disorders Drug Import and Export
5.7 Southeast Asia Genetic Disorders Drug Market Analysis
5.7.1 Southeast Asia Genetic Disorders Drug Production
5.7.2 Southeast Asia Genetic Disorders Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Genetic Disorders Drug Import and Export
5.8 India Genetic Disorders Drug Market Analysis
5.8.1 India Genetic Disorders Drug Production
5.8.2 India Genetic Disorders Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Genetic Disorders Drug Import and Export

6 Genetic Disorders Drug Segment Market Analysis (by Type)
6.1 Global Genetic Disorders Drug Production by Type
6.2 Global Genetic Disorders Drug Revenue by Type
6.3 Genetic Disorders Drug Price by Type

7 Genetic Disorders Drug Segment Market Analysis (by Application)
7.1 Global Genetic Disorders Drug Consumption by Application
7.2 Global Genetic Disorders Drug Consumption Market Share by Application (2014-2019)

8 Genetic Disorders Drug Major Manufacturers Analysis
8.1 Sanofi
8.1.1 Sanofi Genetic Disorders Drug Production Sites and Area Served
8.1.2 Sanofi Product Introduction, Application and Specification
8.1.3 Sanofi Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Vertex
8.2.1 Vertex Genetic Disorders Drug Production Sites and Area Served
8.2.2 Vertex Product Introduction, Application and Specification
8.2.3 Vertex Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Shire
8.3.1 Shire Genetic Disorders Drug Production Sites and Area Served
8.3.2 Shire Product Introduction, Application and Specification
8.3.3 Shire Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Amgen
8.4.1 Amgen Genetic Disorders Drug Production Sites and Area Served
8.4.2 Amgen Product Introduction, Application and Specification
8.4.3 Amgen Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GW Pharmaceuticals
8.5.1 GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
8.5.2 GW Pharmaceuticals Product Introduction, Application and Specification
8.5.3 GW Pharmaceuticals Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer
8.6.1 Pfizer Genetic Disorders Drug Production Sites and Area Served
8.6.2 Pfizer Product Introduction, Application and Specification
8.6.3 Pfizer Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 BioMarin
8.7.1 BioMarin Genetic Disorders Drug Production Sites and Area Served
8.7.2 BioMarin Product Introduction, Application and Specification
8.7.3 BioMarin Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Sarepta
8.8.1 Sarepta Genetic Disorders Drug Production Sites and Area Served
8.8.2 Sarepta Product Introduction, Application and Specification
8.8.3 Sarepta Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Genetic Disorders Drug Market
9.1 Global Genetic Disorders Drug Market Trend Analysis
9.1.1 Global Genetic Disorders Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Genetic Disorders Drug Regional Market Trend
9.2.1 North America Genetic Disorders Drug Forecast 2019-2025
9.2.2 Europe Genetic Disorders Drug Forecast 2019-2025
9.2.3 China Genetic Disorders Drug Forecast 2019-2025
9.2.4 Japan Genetic Disorders Drug Forecast 2019-2025
9.2.5 Southeast Asia Genetic Disorders Drug Forecast 2019-2025
9.2.6 India Genetic Disorders Drug Forecast 2019-2025
9.3 Genetic Disorders Drug Market Trend (Product Type)
9.4 Genetic Disorders Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Genetic Disorders Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Genetic Disorders Drug
Table Global Genetic Disorders Drug Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Genetic Disorders Drug Production Market Share by Types in 2018
Figure Cystic Fibrosis (CF) Product Picture
Figure Duchenne Muscular Dystrophy (DMD) Product Picture
Figure Lysosomal Storage Disease (LSD) Product Picture
Figure Paroxysmal Nocturnal Hemoglobinuria (PNH) Product Picture
Table Global Genetic Disorders Drug Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Genetic Disorders Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Global Genetic Disorders Drug Revenue (Million USD) (2014-2025)
Figure Global Genetic Disorders Drug Production (K Units) (2014-2025)
Figure North America Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Figure Europe Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Figure China Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Figure Japan Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Figure India Genetic Disorders Drug Market Size (Million USD) (2014-2025)
Table Genetic Disorders Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Genetic Disorders Drug in 2018
Figure Manufacturing Process Analysis of Genetic Disorders Drug
Figure Industry Chain Structure of Genetic Disorders Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Genetic Disorders Drug Manufacturing Plants Distribution
Table Genetic Disorders Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Genetic Disorders Drug Capacity (K Units) of Major Manufacturers (2014-2019)
Table Genetic Disorders Drug Production (K Units) of Major Manufacturers (2014-2019)
Table Genetic Disorders Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Genetic Disorders Drug Production Share by Manufacturers in 2018
Table Genetic Disorders Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Genetic Disorders Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Genetic Disorders Drug Revenue Share by Manufacturers in 2018
Table Genetic Disorders Drug Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Genetic Disorders Drug Production by Regions 2014-2019 (K Units)
Table Global Genetic Disorders Drug Production Market Share by Regions 2014-2019
Figure Global Genetic Disorders Drug Production Market Share by Regions in 2018
Table Global Genetic Disorders Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Genetic Disorders Drug Revenue Market Share by Regions 2014-2019
Figure Global Genetic Disorders Drug Revenue Market Share by Regions in 2018
Table Global Genetic Disorders Drug Consumption by Regions 2014-2019 (K Units)
Table Global Genetic Disorders Drug Consumption Market Share by Regions 2014-2019
Figure North America Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure North America Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure Europe Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure Europe Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure China Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure China Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure Japan Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure Japan Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure Southeast Asia Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure India Genetic Disorders Drug Production Growth Rate 2014-2019 (K Units)
Figure India Genetic Disorders Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Genetic Disorders Drug Production, Consumption Import and Export (K Units)
Figure Global Consumption Genetic Disorders Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Genetic Disorders Drug Market Share by Application (2014-2019)
Table Sanofi Genetic Disorders Drug Production Sites and Area Served
Table Sanofi Genetic Disorders Drug Product Introduction, Application and Specification
Table Sanofi Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Sanofi Genetic Disorders Drug Production Market Share (2014-2019)
Figure Sanofi Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Sanofi Genetic Disorders Drug Main Business and Markets Served
Table Vertex Genetic Disorders Drug Production Sites and Area Served
Table Vertex Genetic Disorders Drug Product Introduction, Application and Specification
Table Vertex Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Vertex Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Vertex Genetic Disorders Drug Production Market Share (2014-2019)
Figure Vertex Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Vertex Genetic Disorders Drug Main Business and Markets Served
Table Shire Genetic Disorders Drug Production Sites and Area Served
Table Shire Genetic Disorders Drug Product Introduction, Application and Specification
Table Shire Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Shire Genetic Disorders Drug Production Market Share (2014-2019)
Figure Shire Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Shire Genetic Disorders Drug Main Business and Markets Served
Table Amgen Genetic Disorders Drug Production Sites and Area Served
Table Amgen Genetic Disorders Drug Product Introduction, Application and Specification
Table Amgen Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Amgen Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Amgen Genetic Disorders Drug Production Market Share (2014-2019)
Figure Amgen Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Amgen Genetic Disorders Drug Main Business and Markets Served
Table GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
Table GW Pharmaceuticals Genetic Disorders Drug Product Introduction, Application and Specification
Table GW Pharmaceuticals Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GW Pharmaceuticals Genetic Disorders Drug Production Growth Rate (2014-2019)
Table GW Pharmaceuticals Genetic Disorders Drug Production Market Share (2014-2019)
Figure GW Pharmaceuticals Genetic Disorders Drug Revenue Market Share (2014-2019)
Table GW Pharmaceuticals Genetic Disorders Drug Main Business and Markets Served
Table Pfizer Genetic Disorders Drug Production Sites and Area Served
Table Pfizer Genetic Disorders Drug Product Introduction, Application and Specification
Table Pfizer Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Pfizer Genetic Disorders Drug Production Market Share (2014-2019)
Figure Pfizer Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Pfizer Genetic Disorders Drug Main Business and Markets Served
Table BioMarin Genetic Disorders Drug Production Sites and Area Served
Table BioMarin Genetic Disorders Drug Product Introduction, Application and Specification
Table BioMarin Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table BioMarin Genetic Disorders Drug Production Growth Rate (2014-2019)
Table BioMarin Genetic Disorders Drug Production Market Share (2014-2019)
Figure BioMarin Genetic Disorders Drug Revenue Market Share (2014-2019)
Table BioMarin Genetic Disorders Drug Main Business and Markets Served
Table Sarepta Genetic Disorders Drug Production Sites and Area Served
Table Sarepta Genetic Disorders Drug Product Introduction, Application and Specification
Table Sarepta Genetic Disorders Drug Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sarepta Genetic Disorders Drug Production Growth Rate (2014-2019)
Table Sarepta Genetic Disorders Drug Production Market Share (2014-2019)
Figure Sarepta Genetic Disorders Drug Revenue Market Share (2014-2019)
Table Sarepta Genetic Disorders Drug Main Business and Markets Served
Figure Global Genetic Disorders Drug Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Genetic Disorders Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Genetic Disorders Drug Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Genetic Disorders Drug Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Genetic Disorders Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Genetic Disorders Drug by Type (2019-2025)
Table Global Consumption (K Units) of Genetic Disorders Drug by Application (2019-2025)
Table Genetic Disorders Drug Distributors List
Table Genetic Disorders Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type